H. Kim

PD-L1 expression as a prognostic marker in patients with advanced biliary tract cancer.

Joon-Oh Park, S. Park, Jeeyun Lee, 2020 .

P14.11 Optimal Combination of Biomarkers to Improve the Predictive Value of Immunotherapeutic Response in Non-Small Cell Lung Cancer

S. Kim, Y. J. Kim, K. J. Suh, 2021 .

Hyperprogression after immunotherapy: Clinical implication and genomic alterations in advanced non-small cell lung cancer patients (NSCLC).

Ho Yun Lee, J. Ahn, M. Ahn, 2018 .

Safety of erlotinib in TRUST, a phase IV trial in patients with advanced non-small cell lung cancer (NSCLC): Initial results from the East/South East (E/SE) Asian subgroup

Keunchil Park, Yi-long Wu, H. Kuo, 2007 .

Multiple tracheal metastases of lung cancer: CT and integrated PET/CT findings.

Ho Kim, J. Han, T. Kim, 2010, Clinical radiology.